CCEL
CryoCell International Inc
NYSE MKT: CCEL · HEALTHCARE · MEDICAL CARE FACILITIES
$3.51
-0.28% today
Updated 2026-04-30
Market cap
$29.56M
P/E ratio
—
P/S ratio
0.95x
EPS (TTM)
$-0.32
Dividend yield
3.84%
52W range
$3 – $6
Volume
0.0M
CryoCell International Inc (CCEL) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$3.51
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$7.69
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -8.52%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.